Chairman & Sponsor Disclose 26.19% Stake in Newly Public SPAC
summarizeSummary
Cambridge Acquisition Corp.'s Chairman and Sponsor have filed an initial Schedule 13D, disclosing a combined beneficial ownership of 26.19% of the company's ordinary shares, acquired in connection with the SPAC's recent IPO.
check_boxKey Events
-
Initial 13D Filing
Chairman Michael Cam-Phung and Cambridge Sponsor LLC filed their initial Schedule 13D, establishing their beneficial ownership.
-
Significant Stake Disclosed
The reporting persons collectively own 8,162,167 ordinary shares, representing 26.19% of the company's outstanding shares.
-
Acquisition Details
The stake includes founder shares acquired for $25,000 and private placement units purchased for $4.955 million, totaling $4.98 million in cash outlay.
-
SPAC Sponsor Commitments
The reporting persons have agreed to vote their shares in favor of a business combination and not to redeem shares, aligning with typical SPAC sponsor obligations.
auto_awesomeAnalysis
This initial Schedule 13D filing reveals the foundational ownership structure of Cambridge Acquisition Corp., a newly public SPAC. Michael Cam-Phung, the Chairman, and Cambridge Sponsor LLC, the company's sponsor, collectively hold a substantial 26.19% stake, valued at approximately $81.36 million based on the current stock price. This significant ownership, acquired through founder shares and private placement units, is a standard arrangement for SPACs, where sponsors commit capital and expertise to identify and execute a business combination. The filing details their agreement to vote in favor of a proposed business combination and not to redeem shares, which provides stability and alignment with the SPAC's objective. The disclosure of this large, locked-up insider position is critical for understanding the company's governance and future direction as it seeks a merger target.
At the time of this filing, CAQUU was trading at $9.97 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $199.8M. The 52-week trading range was $9.95 to $10.01. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.